Uncategorised - European Medical Journal

Does Presence of Charcot–Leyden Crystals Predict Polyp Recurrence?

According to new data, Charcot-Leyden crystals in the nasal tissues may predict whether CRSwNP is likely to recur. Read more…

Quality of Life Worsened for Patients with Allergic Rhinitis and Comorbid Asthma

A new study has highlighted the necessity of developing comprehensive approaches to asthma as a comorbidity for allergic rhinitis.

Only Seven Health Symptoms Directly Associated With ‘Long COVID’

New research has surprisingly discovered that individuals suffering long COVID are predisposed to developing only seven health symptoms.

Can Monoclonal Antibodies Reduce Respiratory Syncytial Virus Burden in Children?

A new study revealed a significant decline in RSV-related infections and hospitalisations in children being prescribed monoclonal antibodies.

Embedding Research into Clinical Practice

Ai Lyn Tan joins Jonathan to discuss rheumatology research and its use clinical practice, as well as the emotional burden of arthritis.

Editor's Pick: Therapeutic Biomarkers for Bladder Carcinoma

Bladder cancer (BC) is the fourth most common malignancy in males and shows high prevalence and mortality rates worldwide despite improvements in its management.

Are Age and BMI Linked to Acne Incidence?

Increasing understanding of preadolescent acne epidemiology and risk factors may allow earlier intervention and prevent undesirable sequelae…

Functional Surgery May Reduce Recurrence of Nail Unit Melanoma

Functional surgery may reduce the risk of recurrence in patients with nail unit melanoma with a Breslow thickness lower than 0.8 mm…

Breaking the bias in healthcare AI

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

Neutrophil-Lymphocyte Ratio, Platelets-Lymphocyte Ratio, and High-Resolution CT in Patients with COVID-19

COVID-19 is an abruptly progressing and sometimes lethal contagious disease. It is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan, China, at the end of 2019. The World Health Organization (WHO) announced it as a pandemic in March 2020.